Basic Information
NEC OncoImmunity AS is a bioinformatics company that provides proprietary machine-learning-based software to address the critical knowledge gap in predicting truly immunogenic neoantigens for personalized cancer immunotherapy. NEC OncoImmunity AS is dedicated to developing software solutions to facilitate effective patient selection for cancer immunotherapy and to identify the optimal neoantigen targets for truly personalized cancer vaccines and cell therapies within clinically actionable timeframes.
NEC OncoImmunity AS
The Kingdom of Norway
15~50 people
January 01, 2014
--

